FDA shuffles top drug, biologics leaders in latest leadership shakeup
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human…
Tag: Biologics
Innovent Biologics Bullish on China Obesity Drug Outlook
Innovent Biologics has reported its first profit even as competition from weight-loss generics looms. Speaking exclusively to Bloomberg’s “The China…
ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the 10 Stocks Investors Are Tracking Now. ADMA Biologics snapped a five-day losing…
Ultragenyx Pharmaceutical (RARE) Resubmits Biologics License Application for Gene Therapy Treatment
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. On January 30,…
Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion
Indian pharmaceuticals firm Biocon Ltd. will buy out minority shareholders in Biocon Biologics Ltd. via a mix of cash and…
Biocon Biologics CEO Discusses Merger and IPO Plans
Biocon Biologics Managing Director and CEO Shreehas Tambe says the board has not recommended any action on a potential IPO…